Idarubicin in acute leukemia: results of studies at Memorial Sloan-Kettering Cancer Center

Semin Oncol. 1989 Feb;16(1 Suppl 2):30-4.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Blast Crisis / drug therapy
  • Cytarabine / administration & dosage
  • Cytarabine / adverse effects
  • Daunorubicin / administration & dosage
  • Female
  • Humans
  • Idarubicin / administration & dosage*
  • Idarubicin / adverse effects
  • Leukemia / drug therapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
  • Leukemia, Myeloid, Acute / drug therapy
  • Male
  • Middle Aged
  • Recurrence
  • Remission Induction

Substances

  • Cytarabine
  • Idarubicin
  • Daunorubicin